首页> 美国卫生研究院文献>Cancer Biology Therapy >miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma
【2h】

miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma

机译:miR-506是喉鳞状细胞癌中YAP1依赖性肿瘤抑制因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Laryngeal squamous cell carcinoma (LSCC) accounts for 95% of laryngeal cancer incidence. Tobacco use has been shown to have a linear association with the development of the disease. While early diagnosis and treatment of LSCC are critical in improving the 5-year survival rate and quality of life, diagnosis of early-stage LSCC remains challenging because of the unapparent symptoms. Here, we report that miR-506, a critical regulator in many types of cancers, is aberrantly suppressed in LSCC patient tissues and cultured cancer cells. This is likely responsible for the enhanced production of YAP1 protein, a transcriptional factor that is well known for its oncogenic roles in LSCC malignancy. Statistical analysis has confirmed that the expression levels of miR-506 and YAP1 are strongly correlated with the malignant statuses of patient tumors. Restoring the expression level of miR-506 in cultured LSCC cells significantly inhibited proliferation, migration and invasion of the cells. The miR-506 and YAP1 regulatory network seems to affect at least pathways involved in apoptosis. Our study, for the first time, has demonstrated a tumor suppressive role of miR-506 in LSCC. This opens new opportunities for further exploring the molecular details of the development of the disease and thus will facilitate the development of novel diagnosis and therapeutic strategies.
机译:喉鳞状细胞癌(LSCC)占喉癌发病率的95%。烟草使用已显示与疾病的发展呈线性关系。尽管LSCC的早期诊断和治疗对于提高5年生存率和生活质量至关重要,但由于症状不明显,早期LSCC的诊断仍然具有挑战性。在这里,我们报道miR-506,在许多类型的癌症中的关键调节剂,在LSCC患者组织和培养的癌细胞中被异常抑制。这可能是导致YAP1蛋白产量增加的原因,YAP1蛋白是一种转录因子,众所周知,它在LSCC恶性肿瘤中具有致癌作用。统计分析已经证实,miR-506和YAP1的表达水平与患者肿瘤的恶性程度密切相关。恢复培养的LSCC细胞中miR-506的表达水平可显着抑制细胞的增殖,迁移和侵袭。 miR-506和YAP1调控网络似乎至少影响细胞凋亡相关的途径。我们的研究首次证明了miR-506在LSCC中的肿瘤抑制作用。这为进一步探索疾病发展的分子细节提供了新的机会,因此将促进新型诊断和治疗策略的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号